Open Access
The economic and health burdens of diseases caused by group A Streptococcus in New Zealand
International Journal Of Infectious DiseasesPeer ReviewedJeffrey Can +82020Journals
In preparation for the future arrival of a group A Streptococcus (GAS) vaccine, this study estimated the economic and health burdens of GAS diseases in New Zealand (NZ).

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support